![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1534974
Á¤ÀÚÀºÇà ½ÃÀå : ÇöȲ ºÐ¼® ¹× ¿¹Ãø(2024-2032³â)Sperm Bank Market: Current Analysis and Forecast (2024-2032) |
Á¤ÀÚÀºÇà ½ÃÀåÀº ¾à 4%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÁÖ·Î ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È, °Ç° ¹®Á¦, ȯ°æÀû ¿äÀÎÀÌ Á¤ÀÚÀºÇà¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ Ã¼¿Ü¼öÁ¤(IVF)°ú Àڱà ³» Àΰø¼öÁ¤(IUI)°ú °°Àº ARTÀÇ ±â¼ú ¹ßÀüÀÌ Á¤ÀÚÀºÇà ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 6¿ù Janani´Â ¼¼°è ÃÖÃÊÀÇ °¡Á¤¿ë Á¤¾× °Ë»ç ŰƮ¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ È¸»ç´Â ¶ÇÇÑ Á¤ÀÚ¿¡ ¼Õ»óÀ» ÀÔÈ÷Áö ¾Ê°í ºñ°Ë»ç½Ç¿¡¼ ÃÖ´ë 8½Ã°£ µ¿¾È »ùÇÃÀ» º¸°üÇÒ ¼ö ÀÖ´Â µ¶ÀÚÀûÀÎ ¸Åü¸¦ °³¹ßÇß½À´Ï´Ù.
¼ºñ½º¿¡ µû¶ó ½ÃÀåÀº Á¤ÀÚ º¸Á¸, Á¤¾× °Ë»ç, À¯Àü »ó´ãÀ¸·Î ±¸ºÐµË´Ï´Ù. Á¤ÀÚ º¸Á¸ ºÎ¹®Àº °¡ÀÓ·Â º¸Á¸ ¹× °¡Á· °èȹ ¿É¼ÇÀ» ¿øÇÏ´Â °³Àΰú Ä¿Çÿ¡°Ô ÇʼöÀûÀÎ ¼ºñ½º¸¦ Á¦°øÇÔÀ¸·Î½á Á¤ÀÚ ÀºÇà ½ÃÀå¿¡¼ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÐ¾ß´Â ÈÇпä¹ý µî »ý½Ä´É·ÂÀ» ¼Õ»ó½Ãų ¼ö ÀÖ´Â Ä¡·á¸¦ ¹Þ°í ÀÖ´Â ³²¼º, °³ÀÎÀû ¶Ç´Â Á÷¾÷Àû ÀÌÀ¯·Î Àڳฦ °®Áö ¾ÊÀ¸·Á´Â ³²¼º µî ´Ù¾çÇÑ °í°´ÃþÀ» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. Á¤ÀÚÀºÇàÀº Àå±â º¸Á¸ ¿ë¾×À» Á¦°øÇÔÀ¸·Î½á °í°´ÀÌ »ý½Ä ´É·ÂÀ» È®º¸ÇÒ ¼ö ÀÖµµ·Ï µµ¿Í ½ÃÀåÀÇ Àúº¯À» ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Àνİú ¼ö¿ä Áõ°¡´Â ³Ãµ¿ º¸Á¸ ±â¼úÀÇ ¹ßÀü°ú ÇÔ²² Á¤ÀÚ º¸Á¸ ºÐ¾ßÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Àüü ½ÃÀå ¼¼ºÐÈ ½ÃÀå¿¡¼ ¸Å¿ì Áß¿äÇÑ ±¸¼º ¿ä¼Ò·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
½ÃÀåÀº ±âÁõÀÚ¿¡ µû¶ó ¾Ë·ÁÁø ±âÁõÀÚ, ÀÍ¸í ±âÁõÀÚ, ±âŸ·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áß Æ¯Á¤ ¹®ÈÀû, ¹ýÀû Ãø¸éÀ» ÀÌ¿ëÇÏ¿© ¾Ë·ÁÁø ±âÁõÀÚ Ä«Å×°í¸®°¡ Á¤ÀÚÀºÇà ½ÃÀå¿¡¼ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À͸íÀÇ ±âÁõÀÚ¸¦ ¹Þ¾ÆµéÀÌÁö ¾Ê´Â ¹®È³ª À͸íÀÇ ±âÁõÀÚ°¡ ±ÝÁöµÈ ¹ý·üÀû °üÁ¡¿¡¼ º¼ ¶§, ¾Ë·ÁÁø ±âÁõÀÚ´Â ¹®È¿Í ÇØ´ç ±¹°¡ÀÇ ¹ý·ü¿¡ ºÎÇÕÇϱ⠶§¹®¿¡ °¡Àå ÀûÇÕÇÕ´Ï´Ù. ÀÌ °èÃþÀº ³²¼ºÀÌ Æ¯Á¤ Áúº´À¸·Î ÀÎÇØ ƯÁ¤ À¯ÀüÀû ¹è°æÀ» °¡Áø Á¤ÀÚ¸¦ ¿øÇÒ ¶§ °¡Àå Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ¾Ë·ÁÁø ±âÁõÀÚ°¡ Á¸ÀçÇØ¾ß ÇÑ´Ù´Â »ç½Ç·Î ÀÎÇØ Àå¾Ö°¡ ¹ß»ýÇÒ ¼ö ÀÖÀ¸¸ç, ±× °á°ú ¹Ì·¡ ÀÚ³àÀÇ ¸¸Á·µµ°¡ ³ô¾ÆÁö°í À¯ÀüÀû ¹è°æÀ» ¾Ë ¼ö Àֱ⠶§¹®¿¡ ½É¸®Àû ½ºÆ®·¹½º°¡ ÁÙ¾îµì´Ï´Ù. ÀÌ·¯ÇÑ Ãø¸é¿¡¼ ¾Ë·ÁÁø ±âÁõÀÚ ºÎ¹®Àº ´Ù¾çÇÑ °í°´ ¼±È£µµ¿¡ µû¸¥ ½ÃÀå ¼ö¿ä¸¦ ÀÔÁõÇÏ´Â Áß¿äÇÑ ÈûÀÌ µÇ°í ÀÖ½À´Ï´Ù.
¼öÁ¤ ±â¼ú¿¡ µû¶ó ½ÃÀåÀº ±âÁõÀÚ ¼öÁ¤°ú ü¿Ü¼öÁ¤(IVF)À¸·Î ³ª´¹´Ï´Ù. ÀÌ Áß ±âÁõÀÚ ¼öÁ¤ Ä«Å×°í¸®°¡ Á¤ÀÚ ÀºÇà ½ÃÀå¿¡¼ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÀÌÀ¯´Â ü¿Ü¼öÁ¤(IVF)°ú °°Àº ´Ù¸¥ ART¿¡ ºñÇØ Àú·ÅÇÏ°í °£´ÜÇϱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀº ´Ù¾çÇÑ ºÒÀÓ ¹®Á¦¿¡ ´ëÇÑ Ã¹ ¹øÂ° ¼±Åà ġ·á¹ý Áß Çϳª·Î Á¦½ÃµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¸¶ÄÉÆÃÀ» °ÈÇÏ°í µ¶½Å ¿©¼º, ·¹Áîºñ¾ð, Á¤ÀÚ ¼ö°¡ Àû°Å³ª Á¤ÀÚ ¼ö°¡ ¾ø´Â ³²¼ºÀ» µ½´Â ³ôÀº ¼º°ø·ü·Î ÀÎÇØ °í°´ÃþÀÌ Áõ°¡ÇßÀ¸¸ç, DIÀÇ Á¢±Ù¼º°ú È¿À²¼ºÀ¸·Î ÀÎÇØ ÀÌ ±â¼úÀº ½ÃÀå¿¡¼ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ±â¼ú Çâ»ó°ú ´ëÁßÀÇ ÀÎ½Ä °³¼±À¸·Î ÁøÈÇϰí ÀÖ½À´Ï´Ù. ±â¼ú Çâ»ó°ú ´ëÁßÀÇ ÀÎ½Ä °³¼±À¸·Î ÁøÈÇϰí ÀÖ½À´Ï´Ù.
Á¤ÀÚÀºÇà ½ÃÀå µµÀÔ¿¡ ´ëÇÑ ÀÌÇØ¸¦ µ½±â À§ÇØ ºÏ¹Ì(¹Ì±¹, ij³ª´Ù, ±âŸ À¯·´), À¯·´(µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º, ½ºÆäÀÎ, ÀÌÅ»¸®¾Æ, ±âŸ À¯·´), ¾Æ½Ã¾ÆÅÂÆò¾ç(Áß±¹, ÀϺ», Àεµ, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç), ±âŸ Áö¿ª(Áß±¹, ÀϺ», Àεµ, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç) ¹× ±âŸ Áö¿ª ¼¼°è ½ÃÀå ÇöȲÀ» ±â¹ÝÀ¸·Î ºÐ¼®µÇ¾ú½À´Ï´Ù. Á¸À縦 ±âÁØÀ¸·Î ºÐ¼®µÇ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì Á¤ÀÚÀºÇà ½ÃÀåÀº ÁÖ·Î Àΰø¼öÁ¤ ½Ã¼ú, ±âÁõÀÚ ÇÁ·Î±×·¥, ¿¬±¸ ¸ñÀûÀÇ Àΰ£ Á¤ÀÚ Á¶´Þ, °¡°ø, º¸°ü ¹× ¹è¼Û¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ÀÌ ½ÃÀåÀ» Ư¡Áþ´Â ¿äÀÎÀ¸·Î´Â ºÒÀÓ Áõ°¡, »çȸ¹®ÈÀû º¯È, »ý½Ä±â¼úÀÇ »çȸÀû ¼ö¿ë µîÀÌ ÀÖ½À´Ï´Ù. ³Ãµ¿ º¸Á¸ ¹× À¯ÀüÀÚ °Ë»ç ºÐ¾ßÀÇ »õ·Î¿î °³Ã´Àº Á¤ÀÚ »ùÇÃÀÇ ´É·Â°ú Àӽа¡´É¼ºÀ» Çâ»ó½Ã۰í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀ¸·Î ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÒÀÓ Ä¡·á ±â¾÷ÀÇ ¼ºº°, Ä¡·á ÁßÀÎ »ç¶÷, Ãâ»êÀ» ¹Ì·ç°í ½ÍÀº »ç¶÷ µî ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Àνİú ¿ä±¸°¡ ³ô¾ÆÁö¸é¼ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿ä¼Ò´Â À¯¸®ÇÑ ±ÔÁ¤°ú ƯÁ¤ Áö¿ª¿¡¼ Àß ¹ß´ÞµÈ ºÒÀÓ Å¬¸®´Ð°ú Á¤ÀÚ ÀºÇàÀÇ °¡¿ë¼ºÀÔ´Ï´Ù.
½ÃÀå¿¡ ÁøÃâÇÑ ÁÖ¿ä ±â¾÷À¸·Î´Â Cryos International; New England Cryogenic Center; European Sperm Bank; Fairfax Cryobank, Inc. Spermtech; ReproTech LLC; Xytex Corporation; Cryobank America LLC; The Sperm Bank of California µîÀÌ ÀÖ½À´Ï´Ù.
The global sperm bank market encompasses the collection, storage, and distribution of human sperm for use in fertility treatments and research. It plays a critical role in assisting individuals and couples with reproductive challenges, including those with male infertility, single women, and same-sex couples seeking to conceive. The market is experiencing robust growth driven by several factors: increasing infertility rates due to lifestyle changes and health issues, greater acceptance and demand for assisted reproductive technologies, advancements in cryopreservation techniques, and supportive government regulations. Additionally, the rising awareness and societal acceptance of diverse family structures further propels market expansion, creating a thriving environment for sperm banks globally.
The sperm bank market is set to exhibit a growth rate of about 4%. This is mainly due to lifestyle changes, health issues, and environmental factors driving demand for sperm banks. Furthermore, technological advancements in ART, such as in vitro fertilization (IVF) and intrauterine insemination (IUI), are boosting the sperm bank market. For instance, in June 2021, Janani launched a first-of-its-kind at-home semen testing kit. The company has also developed a unique media that can store a sample without any damage to the sperms for up to 8 hours in non-laboratory conditions.
Based on the service, the market is segmented into sperm storage, semen analysis, and genetic consultation. The sperm storage category is expected to have the largest market share of the sperm bank market by providing essential services for individuals and couples seeking fertility preservation and family planning options. This segment caters to a diverse clientele, including men undergoing medical treatments that may impair fertility, such as chemotherapy, and those who wish to delay parenthood for personal or professional reasons. By offering long-term storage solutions, sperm banks enable clients to secure their reproductive potential, thus expanding the market's reach. The increasing awareness and demand for fertility preservation, coupled with advancements in cryopreservation technology, are propelling the growth of the sperm storage segment, making it a pivotal component of the overall sperm bank market.
Based on the donor, the market is segmented into known donors, anonymous donors, and other donors. Among these, the known donor category is expected to have the largest market share of the sperm bank market by using particular cultural and legal aspects. In cultures that are not embracing anonymous donations or in the legal perspective where anonymous donation is prohibited, known donors are the best fit since they will be responding to the cultures and the law of the land. This segment is most important when a man feels that he desires sperm from a certain genetic background because of certain diseases. Moreover, the disorder can be caused by the fact that there must be known donors which, in turn, will result in a higher level of satisfaction among the children in the future as well as less psychological stress as they will know their genetic background. These aspects make the known donor segment a vital force that substantiates the market needs of different clients with their preferences.
Based on the fertilization technique, the market is segmented into donor insemination and In vitro fertilization. Among these, the donor insemination category is expected to have the largest market share of the sperm bank market because work can be arranged; it is cheap and easier as compared to other ARTs, such as IVF. This procedure is advocated as one of the first-line therapies for a range of fertility concerns, which boosts its utilization. However, increased marketing and high success rates of helping single women, lesbians, and men with low sperm count or none increased its customer base. The accessibility and efficiency of DI make this technology occupy a major share of the market and evolve due to improvements with the help of technology and augmenting public awareness.
For a better understanding of the market adoption of sperm banks, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North American sperm bank market focuses on the procurement, processing, storage, and delivery of human sperm primarily for artificial insemination procedures, donor programs, and research purposes. Some of the factors that characterize this market include rising cases of infertility, changing social culture, and social acceptance of reproductive technologies. New developments in the field of cryopreservation and genetic tests are improving the capacities of sperm samples and the chances of conception, and this is positively contributing to the growth of the market. Furthermore, an increase in the level of consciousness and need for fertility protection companies' gender, those who are going through medical treatments, and those who prefer to postpone the process of childbirth also spur the growth of the market. Another important factor contributing to the growth of this market is the favorable rules and the availability of well-developed fertility clinics and sperm banks in the specified area.
Some of the major players operating in the market include Cryos International; New England Cryogenic Center; European Sperm Bank; Fairfax Cryobank, Inc.; The London Sperm Bank; Indian Spermtech; ReproTech LLC; Xytex Corporation; Cryobank America LLC; and The Sperm Bank of California